Safety of lung cancer surgery during COVID-19 in a pandemic epicenter.

ABSTRACT:

Background

The influence of SARS-CoV-2 on surgery for non-small cell lung cancer needs to be understood to inform clinical decision making during and after the COVID-19 pandemic.

Objective

This study reports on the 90-day rate of infection as well as the morbidity and mortality of lung surgery for cancer in a tertiary care hospital located in a pandemic epicenter.

Methods

We conducted a retrospective review of a prospective database to identify consecutive patients who underwent lung cancer resection before (January 1, 2020-March 10, 2020, group 1; 57 patients) and during the COVID-19 pandemic (March 11, 2020-June 10, 2020, group 2; 41 patients). The primary end point was the occurrence of SARS-CoV-2 infection during the first 90-days after surgery. The secondary outc

SUBMITTER: Villena-Vargas J 

PROVIDER: S-EPMC8885108 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature